Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Mouth Neoplasms 1Laryngeal Neoplasms 1Esophageal Neoplasms 1Alcohol Drinking 1

Interventions

pembrolizumab 3Taxes 2Radiotherapy 2Polymerase Chain Reaction 2Nivolumab 2Nicotine 2Magnetic Resonance Spectroscopy 2Gene Expression Profiling 2Fluorouracil 2Fluorodeoxyglucose F18 2Counseling 2Cisplatin 2Bupropion 2trastuzumab deruxtecan 1motexafin gadolinium 1mogamulizumab 1fluoromisonidazole 1durvalumab 1brodalumab 1belinostat 1Zinc Oxide 1Varenicline 1Tobacco Use Cessation Devices 1Tadalafil 1Surgical Procedures, Operative 1Sucralfate 1Specimen Handling 1Salts 1Rubidium-82 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × Alcoholic Beverages × Gastrointestinal × Clear all
NCT06129487 2025-11-14

Evaluations of Alcohol Warning Labels

University of Connecticut

Phase NA Completed
1,053 enrolled 15 charts
GastrointestinalHead & Neck

Alcohol Drinking, Esophageal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡